Vaishali Pharma initiates 30 products registration
The company also plans to register the similar range of products in the neighbouring countries.
The company also plans to register the similar range of products in the neighbouring countries.
The company is expecting tremendous growth and a better quarterly performance
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.
This acquisition marks Max Healthcare's entry into Lucknow
Subscribe To Our Newsletter & Stay Updated